News Releases

Month Year

Month Year

Oct 28, 2021

Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List
Oct 28, 2021

Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update

--ARIKAYCE® (amikacin liposome inhalation suspension) Now Launched in Three Major Territories; Positive Early Trends in Japan--
Oct 14, 2021

Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021
Oct 5, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 3, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 1, 2021

Insmed To Participate in Five September Conferences
Aug 6, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 5, 2021

Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update

--ARIKAYCE® (amikacin liposome inhalation suspension) Now Launched in Japan; Available in Three Major Territories--
Jul 27, 2021

Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021
Jul 8, 2021

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation